Share buybacks

What companies announce, and what they actually spend, kept side by side.

An announced buyback is a statement of intent. An executed one is cash leaving the balance sheet and shares leaving the float. ORTEX carries both: a global record of more than 233,000 buyback announcements since 1989, and executed repurchases read from company filings, with the cash spent, the shares bought and the authorization still left. The gap between the two is where the signal lives.

Download the brochure (PDF)
233,000+
buyback announcements on file
21,000
companies worldwide
28,000
announcements in the last 12 months
1989
history from
233,000+

buyback announcements tracked since 1989 across 21,000 companies worldwide, with executed spend read from filings and dated to the day the market could first see it.

ORTEX corporate events archive, September 2026.

What you can do with it
Capital allocation

Who is buying back stock, how much, and whether they follow through.

Float and supply

Shares leaving the float, for index, squeeze and ownership work.

Event signals

New programs and accelerations, as they are announced.

Intent and execution, kept apart

Because a large share of announced programs are never fully bought.

01
Announced programs, globally

Every new, extended and increased program worldwide since 1989, with its size and dates.

02
Executed repurchases

Cash spent in the period, shares bought and the value still authorized, read from company filings.

03
Monthly detail

Beneath the quarterly totals, the month-by-month shares bought and the average price paid.

04
Known when the market knew

Every figure is dated to the filing that revealed it, so a backtest only sees what was public on the day.

05
Float impact

Repurchased shares can be canceled or held in treasury. ORTEX keeps the distinction, so a shrinking share count is real.

06
On the corporate timeline

Buybacks sit on the same per-stock timeline as dividends, splits, deals and index changes.

Why ORTEX

Most buyback data stops at the announcement. ORTEX also reads what was actually spent from the filings and dates it to when the market learned it, so an unused program is visible straight away.

License share buybacks for your desk.

Trial access, pricing and licensing from the data sales team. Delivered over the API, as whole-market daily files, into your cloud, or on the ORTEX platform.

API docs
More in filings and disclosures

Coverage, history and figures are as at September 2026. Provided for information purposes only; not investment advice. Past performance is not a guide to future results. See the full data catalog.